Efficacy and safety of the mosquitocidal drug ivermectin to prevent malaria transmission after treatment: a double-blind, randomized, clinical trial.
about
Malaria vector research and control in Haiti: a systematic reviewOral, ultra-long-lasting drug delivery: Application toward malaria elimination goalsNew developments in anti-malarial target candidate and product profilesIvermectin to reduce malaria transmission II. Considerations regarding clinical development pathwayIvermectin to reduce malaria transmission I. Pharmacokinetic and pharmacodynamic considerations regarding efficacy and safetyDeveloping an expanded vector control toolbox for malaria elimination.Ivermectin-treated cattle reduces blood digestion, egg production and survival of a free-living population of Anopheles arabiensis under semi-field condition in south-eastern Tanzania.Ivermectin susceptibility and sporontocidal effect in Greater Mekong Subregion Anopheles.Screening for an ivermectin slow-release formulation suitable for malaria vector controlCharacterization of the target of ivermectin, the glutamate-gated chloride channel, from Anopheles gambiae.Administration of ivermectin to peridomestic cattle: a promising approach to target the residual transmission of human malaria.Malaria vectors and their blood-meal sources in an area of high bed net ownership in the western Kenya highlands.Filling gaps on ivermectin knowledge: effects on the survival and reproduction of Anopheles aquasalis, a Latin American malaria vectorEfficacy and Safety of High-Dose Ivermectin for Reducing Malaria Transmission (IVERMAL): Protocol for a Double-Blind, Randomized, Placebo-Controlled, Dose-Finding Trial in Western Kenya.Cytochrome P450/ABC transporter inhibition simultaneously enhances ivermectin pharmacokinetics in the mammal host and pharmacodynamics in Anopheles gambiae.Ivermectin: a complimentary weapon against the spread of malaria?Inhibition of Plasmodium Liver Infection by Ivermectin.Pilot Study of a Slow-Release Ivermectin Formulation for Malaria Control in a Pig Model.Establishment of the Ivermectin Research for Malaria Elimination Network: updating the research agenda.Ivermectin as a complementary strategy to kill mosquitoes and stop malaria transmission?Residual malaria transmission dynamics varies across The Gambia despite high coverage of control interventions.Drugs in Development for Malaria.Targeting cattle for malaria elimination: marked reduction of Anopheles arabiensis survival for over six months using a slow-release ivermectin implant formulation.Risk factors for asymptomatic malaria infections from seasonal cross-sectional surveys along the China-Myanmar border.Repurposing isoxazoline veterinary drugs for control of vector-borne human diseasesMalaria
P2860
Q26315246-9EF0CB31-308D-4C34-A9F0-E8C359257895Q27901942-C4DF9DAA-9A99-4E78-8A66-A0D653B14BC0Q28468598-4766FECE-CEA3-4211-8AFE-324B4E5774BCQ33593846-ED4138BF-85A4-4199-8B80-5A24F02C739BQ33593852-505B77CB-5943-422B-8039-3927D076758AQ33726544-85A58F57-0EB3-4CDF-9BAD-A6D8CBC6ACCFQ33771668-7394E619-5904-41E6-B2F7-FEF874E5760BQ33882905-A05073FA-B356-4682-9616-DB99A7C4B7FAQ35163829-482B020A-89DB-42BF-8AE2-44BFECD5B942Q35664074-E6DEB8D7-E95F-4724-BD74-474F4CBBA7A0Q36364245-15FEDECF-1DB0-4A85-BA63-72791E7D56B5Q36560576-2699BBB4-6ABE-4DF6-8957-932C84E5C2E4Q37278727-3942A3AE-BBB2-4B53-BF1A-220419B8662CQ37464114-1546F8CF-24AE-40E8-97CC-BB59CB259552Q38936568-1C77ECF7-1B6F-42B9-ACCF-7E1237FB8A37Q40411509-64459EAB-F9F9-407E-94AE-CF3D904C6A9AQ40432477-303BCA64-0F7D-4577-BEDD-B7368E01FEEAQ42319615-1EC5861C-5030-45CF-92D1-B92895FFEA36Q42414575-61B7A1EA-FC0F-4ABE-A619-DF219EC8FA3BQ44146736-01C7364E-F420-4BED-884D-3A69CA80004FQ46688773-A5D14BB5-802A-4C5E-AD68-49E13638CF59Q55278895-AB366C3E-A25F-461F-92B0-EE9D260DA0CBQ55358927-F7325B36-6354-4009-B862-8BAA8C248096Q55530682-6AE06C67-14E5-42BC-91A8-6A60E34912EDQ56346104-F18209FA-EA1D-43A5-BCCF-47C4FB16D6BDQ56378965-F28F07F8-67C1-40B0-95C1-58FEBE76F474
P2860
Efficacy and safety of the mosquitocidal drug ivermectin to prevent malaria transmission after treatment: a double-blind, randomized, clinical trial.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Efficacy and safety of the mos ...... d, randomized, clinical trial.
@en
Efficacy and safety of the mos ...... d, randomized, clinical trial.
@nl
type
label
Efficacy and safety of the mos ...... d, randomized, clinical trial.
@en
Efficacy and safety of the mos ...... d, randomized, clinical trial.
@nl
prefLabel
Efficacy and safety of the mos ...... d, randomized, clinical trial.
@en
Efficacy and safety of the mos ...... d, randomized, clinical trial.
@nl
P2093
P2860
P50
P921
P356
P1476
Efficacy and safety of the mos ...... d, randomized, clinical trial.
@en
P2093
Alfred B Tiono
Alphonse Ouédraogo
Aïssata Barry
Edith C Bougouma
Guido J H Bastiaens
Issa Nebie
Kjerstin H W Lanke
Lawrence Fleckenstein
Maurice San Ouattara
Wamdaogo M Guelbéogo
P2860
P304
P356
10.1093/CID/CIU797
P407
P50
P577
2014-11-19T00:00:00Z